A boost for US stocks amid hopes of vaccine breakthrough
THE vaccine trade is well and truly on, giving the bull market a double jolt of life and volatility.
US stocks gained last week and the Dow Jones Industrial Average completed its strongest opening in the post-World War II era after promising news emerged from a Covid-19 vaccine trial.
With more updates due from vaccine developer Moderna; the US coping with a rapidly building winter wave of novel coronavirus infections and deaths; and the possibility of another round of emergency stimulus, the coming week is sure to see major moves too.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Cordlife served letter of demand, notice of claim from customers
Indonesia’s Vidio is aiming to double subscribers ahead of IPO
DBS Q1 profit up 15% to S$2.95 billion; interim dividend at S$0.54 per share
KKR’s earnings rise 20% on strong management fees, annuities business
Stocks to watch: DBS, Olam, Parkway Life Reit, Japfa, CSE Global
Mastercard’s profit beats as consumer spending defies inflation worries